Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study [0.03%]
评估谢莱卡福尔/泰扎卡福尔/艾伏卡福尔治疗轻度降低和正常肺功能囊性纤维化患者的有效性：真实世界观察性研究
Karin Yaacoby-Bianu,Adi Dagan,Malena Cohen-Cymberknoh et al.
Karin Yaacoby-Bianu et al.
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report [0.03%]
感染后肺并发症：制定研究优先事项以推动领域发展：美国胸科学会工作组报告
Sara C Auld,Ajay Sheshadri,Jennifer Alexander-Brett et al.
Sara C Auld et al.
Continued improvements in the treatment of pulmonary infections have paradoxically resulted in a growing challenge of individuals with postinfectious pulmonary complications (PIPCs). PIPCs have been long recognized after tuberculosis, but r...
Specialists in Chronic Respiratory Failure Should Serve More than Just Ventilator-Dependent Patients [0.03%]
慢性呼吸衰竭专科医生的服务对象不应仅限于机械通气依赖患者
David C Currow,Laure Serresse,Daisy J A Janssen et al.
David C Currow et al.
Reply: Specialists in Chronic Respiratory Failure Should Serve More Than Just Ventilator-Dependent Patients [0.03%]
关于慢性呼吸衰竭专科医师服务对象的回复——不应仅限于机械通气患者
Michelle Cao,Sherri Lynne Katz,John Hansen-Flaschen
Michelle Cao
Endotypic Trait Differences in Class 2/3 Obese Patients with and without Obstructive Sleep Apnea: A Preliminary Analysis of Preoperative Bariatric Surgery Patients [0.03%]
肥胖伴和不伴有阻塞性睡眠呼吸暂停的2/3型肥胖患者的表型特征差异：术前减肥手术患者初步分析结果
Brandon Nokes,Christopher N Schmickl,Raichel Alex et al.
Brandon Nokes et al.
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis [0.03%]
在艾沙卡弗托--tezacaftor-ivacaftor治疗后停止使用高渗盐水和Dornase Alfa对囊性纤维化的影响
Nicole Mayer-Hamblett,Alex H Gifford,Margaret Kloster et al.
Nicole Mayer-Hamblett et al.
Rationale: Evaluating approaches to reduce treatment burden is a research priority among people with cystic fibrosis on highly effective modulators, including elexacaftor-tezacaftor-ivacaftor (ETI). Objectives: We sought to evaluate the imp...
Randomized Controlled Trial
Annals of the American Thoracic Society. 2024 Nov;21(11):1507-1515. DOI:10.1513/AnnalsATS.202404-366OC 2024
Exploring the Role of Testosterone in the Differential Outcomes of Continuous Positive Airway Pressure and Glucagon-like peptide 1 Treatments in Obstructive Sleep Apnea [0.03%]
探索睾酮在阻塞性睡眠呼吸暂停持续气道正压通气和胰高血糖素样肽1治疗不同疗效中的作用
Yu-Hsiang Lin,Tsai-Yu Wang,Chun-Te Wu
Yu-Hsiang Lin
Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after Chronic Obstructive Pulmonary Disease Hospitalization among Older Adults [0.03%]
老年慢性阻塞性肺疾病住院患者的动脉粥样硬化性心血管病再住院风险分析
Christopher L Mosher,Oyomoare L Osazuwa-Peters,Michael G Nanna et al.
Christopher L Mosher et al.
Rationale: Meta-analyses have suggested the risk of cardiovascular disease (CVD) events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation. However, many of these studies have included a broad array of...
Glucagon-like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most? [0.03%]
GLP-1受体激动剂与哮喘加重：哪些患者获益最多？
Tiansheng Wang,Alexander P Keil,John B Buse et al.
Tiansheng Wang et al.
Rationale: Although recent evidence suggested that glucagon-like peptide 1 receptor agonists (GLP1RAs) might reduce the risk of asthma exacerbations, it remains unclear which subpopulations might derive the most benefit from GLP1RA treatmen...